{"id":251245,"date":"2021-12-29T00:00:00","date_gmt":"2021-12-29T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidid0022-biopharma-hepatitis-c-virus-epidemiology-emerging\/"},"modified":"2026-04-17T11:32:15","modified_gmt":"2026-04-17T11:32:15","slug":"epidid0022-biopharma-hepatitis-c-virus-epidemiology-emerging-markets-data","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidid0022-biopharma-hepatitis-c-virus-epidemiology-emerging-markets-data\/","title":{"rendered":"Hepatitis C Virus &#8211; Epidemiology &#8211; Emerging Markets Data"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of hepatitis <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"3\" data-last-change-time=\"1642777182670\" data-time=\"1642777182670\" data-userid=\"2875\" data-username=\"Barbara\">C<\/span> virus (<abbr title=\"hepatitis C virus\">HCV<\/abbr>) comprises epidemiological estimates of key patient populations <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"4\" data-last-change-time=\"1642777191943\" data-time=\"1642777191783\" data-userid=\"2875\" data-username=\"Barbara\">in<\/span> 45 countries. We report both the incidence and prevalence of <abbr title=\"hepatitis C virus\">HCV<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"hepatitis C virus\">HCV<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>How will changes in the levels of exposure to known risk or protective factors affect the number of people diagnosed with <abbr title=\"hepatitis C virus\">HCV<\/abbr> <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"12\" data-last-change-time=\"1642777207814\" data-time=\"1642777207200\" data-userid=\"2875\" data-username=\"Barbara\">each<\/span> year?<\/li>\n<li>How will improvements in survival change the number of people living with <abbr title=\"hepatitis C virus\">HCV<\/abbr>?<\/li>\n<li>Of all people with <abbr title=\"hepatitis C virus\">HCV<\/abbr>, how many in each country have been formally diagnosed?<\/li>\n<li>Of all people diagnosed with <abbr title=\"hepatitis C virus\">HCV<\/abbr>, how many in each country are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"hepatitis C virus\">HCV<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology forecasts 49 <abbr title=\"hepatitis C virus\">HCV<\/abbr> patient populations, <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"24\" data-last-change-time=\"1642777253051\" data-time=\"1642777251558\" data-userid=\"2875\" data-username=\"Barbara\">including<\/span><span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"24\" data-last-change-time=\"1642777253051\" data-time=\"1642777251558\" data-userid=\"2875\" data-username=\"Barbara\"> the<\/span> follow<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"37\" data-last-change-time=\"1642777256079\" data-time=\"1642777255799\" data-userid=\"2875\" data-username=\"Barbara\">ing<\/span>:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed GT3 viremic noncirrhotic prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"42\" data-last-change-time=\"1642777263687\" data-time=\"1642777263687\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Viremic cirrhotic prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"43\" data-last-change-time=\"1642777266139\" data-time=\"1642777266139\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Drug-treat<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"44\" data-last-change-time=\"1642777269498\" data-time=\"1642777269288\" data-userid=\"2875\" data-username=\"Barbara\">ed<\/span> GT3 viremic noncirrhotic<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"110\" data-last-change-time=\"1642777368011\" data-time=\"1642777358057\" data-userid=\"2875\" data-username=\"Barbara\"> <span>sustained virologic response<\/span><\/span> <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"139\" data-last-change-time=\"1642777369759\" data-time=\"1642777369759\" data-userid=\"2875\" data-username=\"Barbara\">(<\/span><span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"54\" data-last-change-time=\"1642777371813\" data-time=\"1642777275312\" data-userid=\"2875\" data-username=\"Barbara\"><abbr title=\"sustained virologic response\">SVR<\/abbr><\/span><span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"54\" data-last-change-time=\"1642777371813\" data-time=\"1642777275312\" data-userid=\"2875\" data-username=\"Barbara\">)<\/span> events<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"57\" data-last-change-time=\"1642777278162\" data-time=\"1642777278162\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Drug-treat<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"58\" data-last-change-time=\"1642777281148\" data-time=\"1642777280961\" data-userid=\"2875\" data-username=\"Barbara\">ed<\/span> GT2 viremic cirrhotic events<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"64\" data-last-change-time=\"1642777285320\" data-time=\"1642777285320\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Viremic noncirrhotic prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"66\" data-last-change-time=\"1642777290328\" data-time=\"1642777290328\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Diagnosed GT2 viremic cirrhotic prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"67\" data-last-change-time=\"1642777294292\" data-time=\"1642777294292\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>GT3 viremic prevalent cases<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"68\" data-last-change-time=\"1642777297321\" data-time=\"1642777297321\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Drug-treat<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"69\" data-last-change-time=\"1642777300431\" data-time=\"1642777300234\" data-userid=\"2875\" data-username=\"Barbara\">ed<\/span> GT4+ viremic noncirrhotic events<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"76\" data-last-change-time=\"1642777305977\" data-time=\"1642777305977\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Drug-treat<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"77\" data-last-change-time=\"1642777309456\" data-time=\"1642777309261\" data-userid=\"2875\" data-username=\"Barbara\">ed<\/span> GT3 viremic cirrhotic <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"86\" data-last-change-time=\"1642777314153\" data-time=\"1642777313536\" data-userid=\"2875\" data-username=\"Barbara\"><abbr title=\"sustained virologic response\">SVR<\/abbr><\/span> events<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"89\" data-last-change-time=\"1642777317367\" data-time=\"1642777317367\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>Drug-treat<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"90\" data-last-change-time=\"1642777319977\" data-time=\"1642777319761\" data-userid=\"2875\" data-username=\"Barbara\">ed<\/span> GT1 viremic noncirrhotic events<span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"97\" data-last-change-time=\"1642777325794\" data-time=\"1642777325794\" data-userid=\"2875\" data-username=\"Barbara\">.<\/span><\/li>\n<li>\u2026 and many more (details available on request).<\/li>\n<\/ul>\n<p>Note: <span class=\"ice-ins ice-cts-1\" data-changedata=\"\" data-cid=\"99\" data-last-change-time=\"1642777331802\" data-time=\"1642777331802\" data-userid=\"2875\" data-username=\"Barbara\">C<\/span>overage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251245","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-hepatitis-c-virus","biopharma-product-epidemiology","biopharma-geography-us","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251245\/revisions"}],"predecessor-version":[{"id":283685,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251245\/revisions\/283685"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}